THU-162 - On-treatment decline in HBeAg level at week 24 predicts for HBeAg seroconversion during long-term tenofovir therapy for HBeAg-positive CHB
| Autor: | Wong, D., Littlejohn, M., Yuen, L., Jackson, K., Mason, H., Gaggar, A., Kitrinos, K., Subramanian, M., Marcellin, P., Buti, M., Janssen, H., Gane, E., Bayliss, J., Sozzi, V., Colledge, D., Locarnini, S., Thompson, A., Revill, P. |
|---|---|
| Zdroj: | In Journal of Hepatology 2017 66(1) Supplement:S259-S260 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect